IRIDEX Stock Pattern Recognition In Neck Pattern
| IRIX Stock | USD 1.33 -0.01 -0.75% |
| Symbol |
Recognition |
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was eleven with a total number of output elements of fifty. The function did not return any valid pattern recognition events for the selected time horizon. The In-Neck Pattern describes IRIDEX trend with bearish continuation signal.
IRIDEX Technical Analysis Modules
Most technical analysis of IRIDEX help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for IRIDEX from various momentum indicators to cycle indicators. When you analyze IRIDEX charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California. Iridex Cp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 119 people. Liquidity and trading activity can influence how quickly new information is reflected in IRIDEX's price. Lower trading activity may introduce occasional variability in execution conditions. IRIDEX has a market cap of 15.08 M, ROE of -139.29%.
Methodology
Unless otherwise specified, financial data for IRIDEX is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. IRIDEX (USA Stocks:IRIX) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The data underlying this report is sourced from public filings and market reference sources, including filings and releases published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Some updates may be delayed based on publication cadence. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
IRIDEX may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Michael Smolkin - Member of Macroaxis Board of DirectorsSome investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards IRIDEX in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, IRIDEX's short interest history, or implied volatility extrapolated from IRIDEX options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Disruptive Technologies Invested few shares | |
 | FinTech Invested over 20 shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Investor Favorites Invested few shares | |
 | Momentum Invested few shares | |
 | ESG Investing Invested few shares | |
 | Blockchain Invested few shares | |
 | Hedge Favorites Invested over 200 shares | |
 | Video Games Invested few shares |
More Resources for IRIDEX Stock Analysis
Understanding IRIDEX typically begins with financial statements and long-term trend review. Ratio context helps frame profitability, efficiency, and growth trends for IRIDEX Stock. Outlined below are key reports that provide context for IRIDEX Stock:IRIDEX has a market cap of 15.08 M, operating margin of -11.3%, ROE of -139.29%. Review Risk vs Return Analysis for broader portfolio context. This reflects a position in IRIDEX within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. New to investing in IRIDEX Stock? Start with our How to Invest in IRIDEX Stock guide for a step-by-step overview.Analysis related to IRIDEX should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Earnings Share -0.32 | Revenue Per Share | Quarterly Revenue Growth 0.078 | Return On Assets | Return On Equity |
IRIDEX's market price can diverge from book value, the accounting figure shown on IRIDEX's balance sheet. IRIDEX's market capitalization is 15.08 M. With a P/B ratio of 269.77, the market values IRIDEX well above its book equity. Enterprise value stands at 28.25 M. Intrinsic value reflects what IRIDEX's fundamentals imply about worth, which may differ from both the trading price and the book figure. Analytical frameworks help reconcile those views.
It is useful to distinguish IRIDEX's value from its trading price, which are computed with different methods. For IRIDEX, key inputs include a P/B ratio of 269.77, a profit margin of -10.04%, ROE of -139.29%, and revenue of 48.67 M. The quoted price is simply the exchange level where supply meets demand.